Office of Research & Development


Registry of In Process and Executed VA CRADAs

To track CRADAs and to create an educational resource, the Technology Transfer Program (TTP) requires VA Medical Centers (VAMCs) or Non-Profit Corporations (NPCs) to register CT CRADAs through the TTP website.

Upon initiating negotiations, please go the website: (This link is available on the intranet only. If you have intranet access, copy and paste the URL into your browser.) (You will need a User ID and password and a VA) website and fill out as much as possible on the eCRADA Registry. If your NPC/VAMC does not have a User ID and password, or you forgot it, please contact Noahline Stuart at to retrieve it. NOTE: This is an intranet and not the internet site.

When the CRADA has been negotiated (signed and completed), you must upload the CRADA to its respective file on the eCRADA Registry. If you choose to wait until the CRADA is negotiated to upload it, then you can do so. If you have any other questions, please contact Noahline Stuart.

Master CRADAs

VA has master template CRADAs where no additional legal or TTP review of the CRADA body is needed. A list of the approved master template CRADAs for Phase III&IV clinical trials are below. Please email Noahline Stuart ( for a copy. If a phase II with these companies is needed please contact Ken Levin (

  • Amgen
  • Astellas
  • Bristol-Myers Squibb
  • Celgene
  • Genentech
  • GSK
  • Merck
  • Novartis
  • OncoGenex
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Sucampo
  • Watson Pharmaceuticals

TTP has also completed negotiations on a master template CRADA with several other companies. The master template CRADAs are going through the concurrence process but are available for immediate single site use. Please email Ken Levin for a copy (

  • AstraZeneca
  • Allegro Diagnostics
  • Lilly & Lilly when Quintiles is the CRO
  • Regenesis Biomedical, Inc.
  • Takeda